Allergic Rhinitis Treatment Market is expected to grow at a CAGR of 4.8% from 2023-2030 : Cognitive Market Research

Market Overview:
Allergic rhinitis called as hay fever refers to an allergic reaction caused by increased sensitivity to allergens in the surrounding environment of the patients. The individual suffers from constant sneezing, runny or stuffy nose, and swelling & redness around the eyes along with watery eyes. The increased amount of pollen in the environment has been seen as one of the most common causes of this allergic reaction. Treatment usually involves medications to help relieve symptoms and avoid triggers. Some common treatments for allergic rhinitis include over-the-counter medications such as nasal steroid sprays, antihistamines or decongestants, and oral corticosteroids.

Summary:
• The global allergic rhinitis treatment market is estimated to be valued at USD 14,999.9 million in 2022 and is expected to exhibit a CAGR of 4.8% during the forecast period (2022-2030).
• North America dominates the global allergic rhinitis market with the highest revenue share.
• The Retail Pharmacies segment is forecasted to dominate the global allergic rhinitis treatment market
• The increasing prevalence of several forms of allergic rhinitis such as seasonal allergic rhinitis, perennial allergic rhinitis, and others among the population is forecasted to dominate the global market
• The anti-histamines segment is anticipated to drive the global market with the highest revenue share

To know more allergic rhinitis treatment Market statistics click here:
https://www.cognitivemarketresearch.com/allergic-rhinitis-treatment-market-report

Market Dynamics
The increasing prevalence of several forms of allergic rhinitis such as seasonal allergic rhinitis, perennial allergic rhinitis, and others among the population is forecasted to dominate the global market. In addition, rising government initiatives to promote awareness regarding allergic rhinitis are forecasted to drive the demand for the allergic rhinitis treatment market. Furthermore, growth in R&D and a rise in awareness among healthcare professionals are expected to offer opportunities for the target market.

Market Segmentation:
By Treatment Type:
• Immunotherapy
o SCIT
o SLITD
o SLITT
• Anti-histamines
• Decongestants
• Leukotriene Receptor Antagonists
• Corticosteroids
The market is segmented into immunotherapy, antihistamine, decongestants, leukotriene receptor antagonists, and corticosteroids. As per cognitive market research analysts, the anti-histamines segment is anticipated to drive the global market with the highest revenue share. This is attributed to the convenience of self-administration, and easy manufacturing of oral dosage forms.

By Route of Administration:
• Oral
• Nasal
• Intraocular
• Intravenous
By route of administration, the market is segmented into oral, nasal, intraocular, and intravenous. An oral segment is forecasted to dominate the global market, due to its ease of convenience.

By Distribution Channel:
• Retail Pharmacies
• Hospital Pharmacies
• E-commerce
The Retail Pharmacies segment is forecasted to dominate the global allergic rhinitis treatment market. This is attributed to the guideline-compliant advice provided by pharmacy assistants for allergic rhinitis.

Competitive Analysis for The allergic rhinitis treatment Market:
Merck, Johnson& Johnson, Sanofi, GlaxoSmithKline, Novartis

Get free sample pages of latest published The allergic rhinitis treatment Market Report:
https://www.cognitivemarketresearch.com/allergic-rhinitis-treatment-market-report/report_enquiry/4

Regional Analysis
North America dominates the global allergic rhinitis market with the highest revenue share. This is attributed to the presence of major key players and the availability of innovative medications for treatment in the country in the region. Furthermore, Asia-Pacific is forecasted to dominate the global market, due to the continuous developments in emerging countries such as India and China.

News
Glenmark Pharma launched its nasal spray Ryaltris
In May 2021, Glenmark Pharma launched its nasal spray Ryaltris, used for the treatment of moderate to severe allergic rhinitis, in India.

Browse Here For Full TOC:
Table of Content (Revenue USD Edition), (Enquire about Volume/Consumption Edition Data)
Chapter 1 Industrial Insight and Market Scope
• 1.1 Global Allergic Rhinitis Treatment Industry Introduction
• 1.2 Objectives of the Study
• 1.3 USP of the Report
• 1.4 Who is this report for?
• 1.5 Designing of Market Scope
1.5.1 Allergic Rhinitis Treatment Market Segmentation
1.5.1 Allergic Rhinitis Treatment Market Regional Fragmentation
1.5.1 Allergic Rhinitis Treatment Market Players
• 1.6 Report Duration
Chapter 2 Research MethodologyReview Complete Research Methodology
Chapter 3 Executive Summary of Allergic Rhinitis Treatment Market
• 3.1 Global Allergic Rhinitis Treatment Market Size 2018 - 2030, (USD Million)
• 3.2 Global Allergic Rhinitis Treatment Market Statistics 2022: Snapshot
Chapter 4 Global Allergic Rhinitis Treatment Market Overview
Chapter 5 Competitive Analysis (Subject to Availability)
Chapter 6 Qualitative Analysis
Chapter 7 Company Profiling (Subject to Availability)
Chapter 8 Global Allergic Rhinitis Treatment Market by Type Segmentation Analysis (2018-2030)
Chapter 9 Global Allergic Rhinitis Treatment Market by Application Segmentation Analysis (2018-2030)
Chapter 10 Global Allergic Rhinitis Treatment Market Regional Analysis
Chapter 11 North America Allergic Rhinitis Treatment Market Outlook (2018 - 2030)
Chapter 12 Europe Allergic Rhinitis Treatment Market Outlook (2018 - 2030)
Chapter 13 Asia Pacific Allergic Rhinitis Treatment Market Outlook (2018 - 2030)
Chapter 14 Latin America Allergic Rhinitis Treatment Market Outlook (2018 - 2030)
Chapter 15 Middle East and Africa Allergic Rhinitis Treatment Market Outlook (2018 -2030)
Chapter 16 Research Findings

To know more allergic rhinitis treatment Market TOC click here:
https://www.cognitivemarketresearch.com/allergic-rhinitis-treatment-market-report#table_of_contents
Related Reports:
Allergic Rhinitis Drugs Market:
https://www.cognitivemarketresearch.com/allergic-rhinitis-drugs-market-report
Allergy Immunotherapy Market:
https://www.cognitivemarketresearch.com/allergy-immunotherapy-market-report
States Allergic Rhinitis Drugs Market:
https://www.cognitivemarketresearch.com/states-allergic-rhinitis-drugs-market-report
Allergic Rhinitis Market:
https://www.cognitivemarketresearch.com/allergic-rhinitis-market-report

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Nicolas Shaw
Cognitive Market Research
20 N State Street,Chicago,
Illinois, 60602
United States
USA: +1 312-376-8303
Europe and UK: (+44) 20-8144-9523
Asia Pacific: (+852) 81930785
Email: sales@cognitivemarketresearch.com
Website: https://www.cognitivemarketresearch.com/about-us

About Cognitive Market Research Company :
Cognitive Market Research has evolved as one leading market research and consulting firm and it provides services across multiple domains. Cognitive Market Research gathers and analyzes data about customers, competitors, distributors, and other market actors and forces operational across the value chain. As a market research company, we follow a complete process of gathering information about the target market and end-use industries to verify the complete journey of the product or service in the global market. It helps our readers understand the demand and viability of their product/service and how it might perform in the real world and help them to build business strategies accordingly.

This release was published on openPR.